, operates the business of manufacturing and distribution of dialysis and medical equipment, later in February 2018, NCLpurchased some shares from a shareholder, making it the major shareholder with 52.80% of
% % 2020 % 2019 % % Revenue from sale 272.47 41.07% 389.02 71.31% -29.96% 600.81 60.91% 795.91 66.61% -24.51% Revenue from manufacturing and service 105.03 15.83% 147.41 27.02% -28.75% 216.52 21.95% 376.15
details: Revenues Structure 1. The revenues of manufacturing and distributing of Food Ingredients that are classified into 6 categories as the followings: 1.1 Flavour, Fragrance & Color 1.2 Food Coating 1.3
Baht 852.55 million, together with the decrease of regular transactions of Trading at the amount of Baht 411.37 million and the decrease of revenue from Manufacturing-Energy (PPP) at the amount of Baht
13.0% in Q4 2022 to 11.5% in Q4 2023 due to lower production volume of automotive parts manufacturing business. However, Gross profit margin was within our target Gross profit margin of 10-12% Selling
noteworthy that our revenue growth outperformed the industry growth in terms of production volume which declined 6.0% due to the following reasons: 1) Automotive Parts Business; Higher order, new product
lower production volume of automotive parts manufacturing business, mainly from Thailand operation. Selling and administrative expenses increased by 4.4% from Baht 440.4 million in Q1 2023 to Baht 459.9
Analysis for the 3rd quarter of year 2022 2 in revenue was higher than the industry growth (in terms of production volume) of 34.5% for the following reasons: 1) Automotive Parts Business; Higher volume from
10,608 / ton or 61.93%, comparing to the 1st quarter of 2014. Due to decreased in Biodiesel production as mentioned above and the Company used most of its by-products as raw materials in B100 production to
2014. Due to decreased in Biodiesel production as mentioned above and the Company used most of its by-products as raw materials in B100 production to reduce Biodiesel’s production cost, which made